1. |
Yan Y, Andriole GL, Humphrey PA, et al. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors . Cancer 2002; 95:1239-46.
|
2. |
Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22:86-92.
|
3. |
Mill醤-Rodr韌uez F, Ch閏hile-Toniolo G, Salvador-Bayarri J, et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163:73-8.
|
4. |
Cheng L, Weaver AL, Leibovich BC , et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 2000; 88:2326-32.
|
5. |
Proctor I, Stoeber K, Williams GH. Biomarkers in bladder cancer. Histopathology 2010; 57:1-13.
|
6. |
Andius P, Johansson SL, Holm鋘g S. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion. Urology 2007; 70:758-62.
|
7. |
van Rhijn BW, Burqer M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 2009; 56:430-42.
|
8. |
de Vere White RW, Stapp E. Predicting prognosis in patients with superficial bladder cancer. Oncology ( Williston Park ) 1998; 12:1717-23 .
|
9. |
Matalka I, Bani-Hani K, Shotar A, et al. Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Singapore Med J 2008; 49:790-4.
|
10 |
Rafique M, Javed AA. Clinico-pathological features of bladder carcinoma: experience from a tertiary care hospital of Pakistan . Int Urol Nephrol 2006; 38:247-50.
|
11 |
Messing EM, Young TB, Hunt VB, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995; 45:387-96.
|
12 |
Pan CC, Chang YH, Chen KK, et al. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 2010; 133:788-95.
|
13 |
Kikuchi E, Fujimoto H, Mizutani Y, et al. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan : 1999-2001 report from the Japanese Urological Association. Int J Urol 2009; 16:279-86.
|
14 |
Gofrit ON , Shapiro A, Pode D, et al. Subepithelial growth patterns in urothelial carcinoma-frequency and prognostic significance. Urol Oncol 201 2; 30:49-54.
|
15 |
Kishi K, Hirota T, Matsumoto K, et al. Carcinoma of the bladder: a clinical and pathological analysis of 87 autopsy cases. J Urol 1981; 125:36-9.
|
16 |
Shinagare AB , Ramaiya NH , Jaqannathan JP, et al. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol 2011; 196:117-22.
|
17 |
Nishiyama H, Habuchi T, Watanabe J, et al. Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990 -2000 in Japan . Eur Urol 2004; 45:176-81.
|
18 |
Thieblemont C, Fendler JP, Trillet-Lenoir V, et al. Prognostic factors of survival in infiltrating urothelial bladder carcinoma. a retrospective study of 158 patients treated by radical cystectomy. Bull Cancer 1996; 83:139-46.
|
19 |
Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000; 55: 876-80.
|
20 |
Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003; 170:1765-71.
|
21 |
Honma I, Masumori N, Sato E, et al. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors . Urology 2004; 64:744-8.
|
22 |
Heney NM , Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130:1083-6.
|
23 |
Herr HW. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol 1997; 15:84-8.
|
24 |
Lipponen PK , Eskelinen M, Jauhiainen K, et al. Clinical prognostic factors in transitional cell cancer of the bladder. Uro Int 1993; 50:192-7.
|